{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T18:20:04Z","timestamp":1772907604631,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.ijantimicag.2009.05.012","type":"journal-article","created":{"date-parts":[[2009,7,4]],"date-time":"2009-07-04T08:30:58Z","timestamp":1246696258000},"page":"309-314","source":"Crossref","is-referenced-by-count":37,"title":["In vitro susceptibility of Burkholderia pseudomallei to antimicrobial peptides"],"prefix":"10.1016","volume":"34","author":[{"given":"Sakawrat","family":"Kanthawong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamran","family":"Nazmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surasakdi","family":"Wongratanacheewin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan G.M.","family":"Bolscher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanaporn","family":"Wuthiekanun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suwimol","family":"Taweechaisupapong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2009.05.012_bib1","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1128\/CMR.18.2.383-416.2005","article-title":"Melioidosis: epidemiology, pathophysiology, and management","volume":"18","author":"Cheng","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2009.05.012_bib2","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/S0140-6736(03)13374-0","article-title":"Melioidosis","volume":"361","author":"White","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2009.05.012_bib3","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/0035-9203(95)90104-3","article-title":"A prospective comparison of co-amoxiclav and the combination of chloramphenicol, doxycycline, and co-trimoxazole for the oral maintenance treatment of melioidosis","volume":"89","author":"Rajchanuvong","year":"1995","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.ijantimicag.2009.05.012_bib4","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/0035-9203(91)90391-B","article-title":"Amoxycillin\u2013clavulanic acid treatment of melioidosis","volume":"85","author":"Suputtamongkol","year":"1991","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.ijantimicag.2009.05.012_bib5","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/jac\/dkh471","article-title":"Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents","volume":"54","author":"Thibault","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2009.05.012_bib6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0924-8579(00)00334-4","article-title":"Antibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosis","volume":"17","author":"Jenney","year":"2001","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2009.05.012_bib7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/jac\/28.2.321","article-title":"Development of resistance to ceftazidime and co-amoxiclav in Pseudomonas pseudomallei","volume":"28","author":"Dance","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2009.05.012_bib8","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0924-8579(99)00071-0","article-title":"Imipenem for the treatment of melioidosis","volume":"12","author":"Minassian","year":"1999","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2009.05.012_bib9","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1128\/AAC.48.5.1763-1765.2004","article-title":"Outcomes of patients with melioidosis treated with meropenem","volume":"48","author":"Cheng","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2009.05.012_bib10","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nrmicro1385","article-title":"Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei","volume":"4","author":"Wiersinga","year":"2006","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijantimicag.2009.05.012_bib11","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1128\/JCM.31.2.238-243.1993","article-title":"Ribotype analysis of Pseudomonas pseudomallei isolates","volume":"31","author":"Sexton","year":"1993","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2009.05.012_bib12","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1007\/s00018-007-6475-6","article-title":"Cationic host defence peptides: innate immune regulatory peptides as a novel approach for treating infections","volume":"64","author":"Mookherjee","year":"2007","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.ijantimicag.2009.05.012_bib13","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1096\/fj.08-112003","article-title":"Histatins are the major wound-closure stimulating factors in human saliva as identified in a cell culture assay","volume":"22","author":"Oudhoff","year":"2008","journal-title":"FASEB J"},{"key":"10.1016\/j.ijantimicag.2009.05.012_bib14","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.4049\/jimmunol.175.3.1776","article-title":"The human \u03b2-defensins (-1, -2, -3, -4) and cathelicidin LL-37 induce IL-18 secretion through p38 and ERK MAPK activation in primary human keratinocytes","volume":"175","author":"Niyonsaba","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.ijantimicag.2009.05.012_bib15","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ijantimicag.2004.09.005","article-title":"Antimicrobial peptides: premises and promises","volume":"24","author":"Reddy","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2009.05.012_bib16","doi-asserted-by":"crossref","first-page":"4922","DOI":"10.1128\/IAI.64.12.4922-4927.1996","article-title":"Antiendotoxin activity of cationic peptide antimicrobial agents","volume":"64","author":"Gough","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijantimicag.2009.05.012_bib17","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/415389a","article-title":"Antimicrobial peptides of multicellular organisms","volume":"415","author":"Zasloff","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ijantimicag.2009.05.012_bib18","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1432-1033.1997.00614.x","article-title":"Gloverin, an antibacterial protein from the immune hemolymph of Hyalophora pupae","volume":"247","author":"Axen","year":"1997","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.ijantimicag.2009.05.012_bib19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0966-842X(96)30013-9","article-title":"Bacterial responses to host-defense peptides","volume":"4","author":"Groisman","year":"1996","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.ijantimicag.2009.05.012_bib20","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1128\/IAI.61.7.2978-2984.1993","article-title":"Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine","volume":"61","author":"Boman","year":"1993","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijantimicag.2009.05.012_bib21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1006\/bbrc.1998.8159","article-title":"Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions","volume":"244","author":"Park","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ijantimicag.2009.05.012_bib22","doi-asserted-by":"crossref","first-page":"13573","DOI":"10.1074\/jbc.271.23.13573","article-title":"Purification and characterization of N-\u03b2-alanyl-5-S-glutathionyl-3,4-dihydroxyphenylalanine, a novel antibacterial substance of Sarcophaga peregrina (flesh fly)","volume":"271","author":"Leem","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijantimicag.2009.05.012_bib23","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1042\/bj20031785","article-title":"Interactions of histatin 5 and histatin 5-derived peptides with liposome membranes: surface effects, translocation and permeabilization","volume":"379","author":"Den Hertog","year":"2004","journal-title":"Biochem J"},{"key":"10.1016\/j.ijantimicag.2009.05.012_bib24","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1042\/BJ20042099","article-title":"Candidacidal effects of two antimicrobial peptides: histatin 5 causes small membrane defects, but LL-37 causes massive disruption of the cell membrane","volume":"388","author":"Den Hertog","year":"2005","journal-title":"Biochem J"},{"key":"10.1016\/j.ijantimicag.2009.05.012_bib25","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1016\/j.peptides.2005.05.014","article-title":"Histatin and lactoferrin derived peptides: antimicrobial properties and effects on mammalian cells","volume":"26","author":"Stallmann","year":"2005","journal-title":"Peptides"},{"key":"10.1016\/j.ijantimicag.2009.05.012_bib26","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.peptides.2003.12.006","article-title":"Lactoferrampin: a novel antimicrobial peptide in the N1-domain of bovine lactoferrin","volume":"25","author":"Van der Kraan","year":"2004","journal-title":"Peptides"},{"key":"10.1016\/j.ijantimicag.2009.05.012_bib27","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/j.peptides.2005.03.056","article-title":"Effect of amino acid substitutions on the candidacidal activity of LFampin 265-284","volume":"26","author":"Van der Kraan","year":"2005","journal-title":"Peptides"},{"key":"10.1016\/j.ijantimicag.2009.05.012_bib28","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1099\/0022-1317-49-12-1075","article-title":"Monoclonal antibody-based rapid identification of Burkholderia pseudomallei in blood culture fluid from patients with community-acquired septicaemia","volume":"49","author":"Anuntagool","year":"2000","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2009.05.012_bib29","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1099\/00222615-45-6-408","article-title":"Biochemical characteristics of clinical and environmental isolates of Burkholderia pseudomallei","volume":"45","author":"Wuthiekanun","year":"1996","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2009.05.012_bib30","doi-asserted-by":"crossref","first-page":"759","DOI":"10.4269\/ajtmh.2002.66.759","article-title":"Short report: a rapid method for the differentiation of Burkholderia pseudomallei and Burkholderia thailandensis","volume":"66","author":"Wuthiekanun","year":"2002","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ijantimicag.2009.05.012_bib31","doi-asserted-by":"crossref","first-page":"348","DOI":"10.4269\/ajtmh.2006.74.348","article-title":"Lipopolysaccharide heterogeneity among Burkholderia pseudomallei from different geographic and clinical origins","volume":"74","author":"Anuntagool","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ijantimicag.2009.05.012_bib32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.micpath.2005.06.001","article-title":"Virulence of Burkholderia pseudomallei does not correlate with biofilm formation","volume":"39","author":"Taweechaisupapong","year":"2005","journal-title":"Microb Pathog"},{"key":"10.1016\/j.ijantimicag.2009.05.012_bib33","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1128\/AAC.35.8.1635","article-title":"Pseudomonas pseudomallei resistance to \u03b2-lactam antibiotics due to alterations in the chromosomally encoded \u03b2-lactamase","volume":"35","author":"Godfrey","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2009.05.012_bib34","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/jac\/37.3.611","article-title":"In-vitro activity of carbapenem antibiotics against \u03b2-lactam susceptible and resistant strains of Burkholderia pseudomallei","volume":"37","author":"Smith","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2009.05.012_bib35","unstructured":"National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility testing for bacteria that grow aerobically, approved standard. Document M7-A5. Wayne, PA: NCCLS, 2000."},{"key":"10.1016\/j.ijantimicag.2009.05.012_bib36","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1128\/AAC.42.9.2206","article-title":"Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils","volume":"42","author":"Turner","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2009.05.012_bib37","first-page":"1","article-title":"Cathelicidin LL-37: LPS-neutralizing, pleiotropic peptide","volume":"14","author":"Golec","year":"2007","journal-title":"Ann Agric Environ Med"},{"key":"10.1016\/j.ijantimicag.2009.05.012_bib38","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1074\/jbc.273.6.3718","article-title":"Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37","volume":"273","author":"Johansson","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijantimicag.2009.05.012_bib39","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.1699-0463.1999.tb01499.x","article-title":"Lactoferrin: a multifunctional glycoprotein","volume":"107","author":"Vorland","year":"1999","journal-title":"APMIS"},{"key":"10.1016\/j.ijantimicag.2009.05.012_bib40","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.1021\/bi972323m","article-title":"Three-dimensional solution structure of lactoferricin B, an antimicrobial peptide derived from bovine lactoferrin","volume":"37","author":"Hwang","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijantimicag.2009.05.012_bib41","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1139\/o06-042","article-title":"Distinct bactericidal activities of bovine lactoferrin peptides LFampin 268-284 and LFampin 265-284: Asp-Leu-Ile makes a difference","volume":"84","author":"Van der Kraan","year":"2006","journal-title":"Biochem Cell Biol"},{"key":"10.1016\/j.ijantimicag.2009.05.012_bib42","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1099\/00221287-146-10-2543","article-title":"Role of Pseudomonas aeruginosa PhoP-phoQ in resistance to antimicrobial cationic peptides and aminoglycosides","volume":"146","author":"Macfarlane","year":"2000","journal-title":"Microbiology"},{"key":"10.1016\/j.ijantimicag.2009.05.012_bib43","doi-asserted-by":"crossref","first-page":"4911","DOI":"10.1128\/JB.00451-07","article-title":"Release of the lipopolysaccharide deacylase PagL from latency compensates for a lack of lipopolysaccharide aminoarabinose modification-dependent resistance to the antimicrobial peptide polymyxin B in Salmonella enterica","volume":"189","author":"Kawasaki","year":"2007","journal-title":"J Bacteriol"},{"key":"10.1016\/j.ijantimicag.2009.05.012_bib44","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0140-6736(89)90768-X","article-title":"Halving of mortality of severe melioidosis by ceftazidime","volume":"2","author":"White","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2009.05.012_bib45","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1172\/JCI17545","article-title":"An angiogenic role for the human peptide antibiotic LL-37\/hCAP-18","volume":"111","author":"Koczulla","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ijantimicag.2009.05.012_bib46","doi-asserted-by":"crossref","first-page":"L842","DOI":"10.1152\/ajplung.00286.2004","article-title":"Human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure","volume":"289","author":"Shaykhiev","year":"2005","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.ijantimicag.2009.05.012_bib47","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1034\/j.1399-6576.2003.00045.x","article-title":"Effects of human cathelicidin antimicrobial peptide LL-37 on lipopolysaccharide-induced nitric oxide release from rat aorta in vitro","volume":"47","author":"Ciornei","year":"2003","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.ijantimicag.2009.05.012_bib48","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s10529-005-0936-5","article-title":"Human antimicrobial peptides: defensins, cathelicidins and histatins","volume":"27","author":"De Smet","year":"2005","journal-title":"Biotechnol Lett"},{"key":"10.1016\/j.ijantimicag.2009.05.012_bib49","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1128\/AAC.50.5.1672-1679.2006","article-title":"LL-37 protects rats against lethal sepsis caused by gram-negative bacteria","volume":"50","author":"Cirioni","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2009.05.012_bib50","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1128\/IAI.00080-07","article-title":"Endogenous interleukin-18 improves the early antimicrobial host response in severe melioidosis","volume":"75","author":"Wiersinga","year":"2007","journal-title":"Infect Immun"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857909002830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857909002830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T07:17:38Z","timestamp":1589959058000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857909002830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0924857909002830"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2009.05.012","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}